GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Return-on-Tangible-Asset

Biotech Growth Trust (The) (LSE:BIOG) Return-on-Tangible-Asset : 49.10% (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Biotech Growth Trust (The)'s annualized Net Income for the quarter that ended in Mar. 2024 was £176.67 Mil. Biotech Growth Trust (The)'s average total tangible assets for the quarter that ended in Mar. 2024 was £359.82 Mil. Therefore, Biotech Growth Trust (The)'s annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 49.10%.

The historical rank and industry rank for Biotech Growth Trust (The)'s Return-on-Tangible-Asset or its related term are showing as below:

LSE:BIOG' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -37.59   Med: 9.72   Max: 44.32
Current: 20.72

During the past 13 years, Biotech Growth Trust (The)'s highest Return-on-Tangible-Asset was 44.32%. The lowest was -37.59%. And the median was 9.72%.

LSE:BIOG's Return-on-Tangible-Asset is ranked better than
93.7% of 1715 companies
in the Asset Management industry
Industry Median: 3.16 vs LSE:BIOG: 20.72

Biotech Growth Trust (The) Return-on-Tangible-Asset Historical Data

The historical data trend for Biotech Growth Trust (The)'s Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Return-on-Tangible-Asset Chart

Biotech Growth Trust (The) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.63 38.15 -37.59 -10.48 19.33

Biotech Growth Trust (The) Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.32 16.89 -38.71 -8.22 49.10

Competitive Comparison of Biotech Growth Trust (The)'s Return-on-Tangible-Asset

For the Asset Management subindustry, Biotech Growth Trust (The)'s Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Growth Trust (The)'s Return-on-Tangible-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s Return-on-Tangible-Asset falls into.



Biotech Growth Trust (The) Return-on-Tangible-Asset Calculation

Biotech Growth Trust (The)'s annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=74.6/( (360.509+411.42)/ 2 )
=74.6/385.9645
=19.33 %

Biotech Growth Trust (The)'s annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=176.672/( (308.211+411.42)/ 2 )
=176.672/359.8155
=49.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Mar. 2024) net income data.


Biotech Growth Trust (The)  (LSE:BIOG) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Biotech Growth Trust (The) Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Growth Trust (The) (LSE:BIOG) Business Description

Traded in Other Exchanges
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines